---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-017786"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T18:53:31.676969+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q3 revenue $69.6M (+7% YoY); net income $22.3M vs loss; updates FY guidance

## Summary
- Revenue $69.6M, up 7% YoY; lymphedema +15%, airway clearance -36%.
- Net income $22.3M ($0.94 diluted EPS) vs loss of $2.3M ($0.11 loss) in Q3 2022.
- Adjusted EBITDA $7.7M vs $7.2M; operating income $8.0M vs loss of $1.6M.
- FY2023 revenue guidance narrowed to $273-277M from $274-278M, ~11-12% growth.
- Sherri Ferstler appointed SVP Sales; Vindell Washington, M.D. added to Board.

## SEC filing metadata
- accession: 0001558370-23-017786
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000155837023017786/0001558370-23-017786-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000155837023017786/tcmd-20231106x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-017786
- JSON: https://secwatch.observer/filing/0001558370-23-017786.json
- Plain text: https://secwatch.observer/filing/0001558370-23-017786.txt

## Key facts
- Earnings Releases
  TACTILE SYSTEMS TECHNOLOGY INC reported third quarter ended September 30, 2023 results: revenue $69.6 million, net income $22.3 million, EPS $0.94 per diluted share. Guidance reaffirmed.
  - Period: third quarter ended September 30, 2023
  - Revenue: $69.6 million
  - Net income: $22.3 million
  - EPS: $0.94 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: with chronic disorders , today reported financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Summary: ● Revenue increased 7% year-over-year to $69.6 million, compared to $65.3 million in third quarter 2022 ● Lymphedema revenue increased 15% ● Airway clearance revenue decreased 36% ● Operating income of $8.0 million, compared to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1027838/000155837023017786/0001558370-23-017786-index.htm
- Earnings Releases
  TACTILE SYSTEMS TECHNOLOGY INC reported nine months ended September 30, 2023 results: revenue $196.8 million, net income $20.3 million, EPS $0.88 per diluted share.
  - Period: nine months ended September 30, 2023
  - Revenue: $196.8 million
  - Net income: $20.3 million
  - EPS: $0.88 per diluted share
  - Result: reported results
  source text: Total revenue for the nine months ended September 30, 2023, increased $23.9 million, or 13.8%, to $196.8 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1027838/000155837023017786/0001558370-23-017786-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.